Biotechnology Fund Class Fund Price Prediction
| RYCFX Fund | USD 44.57 0.65 1.44% |
Momentum 70
Buy Stretched
Oversold | Overbought |
Using Biotechnology Fund hype-based prediction, you can estimate the value of Biotechnology Fund Class from the perspective of Biotechnology Fund response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Biotechnology Fund to buy its mutual fund at a price that has no basis in reality. In that case, they are not buying Biotechnology because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell mutual funds at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Biotechnology Fund after-hype prediction price | USD 30.11 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as fund price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Biotechnology |
Biotechnology Fund After-Hype Price Density Analysis
As far as predicting the price of Biotechnology Fund at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Biotechnology Fund or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Mutual Fund prices, such as prices of Biotechnology Fund, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Biotechnology Fund Estimiated After-Hype Price Volatility
In the context of predicting Biotechnology Fund's mutual fund value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Biotechnology Fund's historical news coverage. Biotechnology Fund's after-hype downside and upside margins for the prediction period are 26.54 and 49.03, respectively. We have considered Biotechnology Fund's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Biotechnology Fund is very steady at this time. Analysis and calculation of next after-hype price of Biotechnology Fund Class is based on 3 months time horizon.
Biotechnology Fund Mutual Fund Price Outlook Analysis
Have you ever been surprised when a price of a Mutual Fund such as Biotechnology Fund is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Biotechnology Fund backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Fund price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Biotechnology Fund, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.62 | 3.60 | 14.69 | 0.67 | 4 Events / Month | 1 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
44.57 | 30.11 | 32.44 |
|
Biotechnology Fund Hype Timeline
Biotechnology Fund Class is at this time traded for 44.57. The entity has historical hype elasticity of -14.69, and average elasticity to hype of competition of 0.67. Biotechnology is forecasted to decline in value after the next headline, with the price expected to drop to 30.11. The average volatility of media hype impact on the company price is about 15.19%. The price reduction on the next news is expected to be -32.44%, whereas the daily expected return is at this time at 0.62%. The volatility of related hype on Biotechnology Fund is about 335.4%, with the expected price after the next announcement by competition of 45.24. The company last dividend was issued on the 10th of December 2019. Assuming the 90 days horizon the next forecasted press release will be in about 4 days. Check out Biotechnology Fund Basic Forecasting Models to cross-verify your projections.Biotechnology Fund Related Hype Analysis
Having access to credible news sources related to Biotechnology Fund's direct competition is more important than ever and may enhance your ability to predict Biotechnology Fund's future price movements. Getting to know how Biotechnology Fund's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Biotechnology Fund may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PARJX | T Rowe Price | 0.00 | 0 per month | 0.13 | 0.04 | 0.72 | (0.60) | 4.70 | |
| MRHYX | Msift High Yield | 5.41 | 2 per month | 0.00 | (0.41) | 0.24 | (0.23) | 0.47 | |
| ARTFX | Artisan High Income | (0.01) | 1 per month | 0.00 | (0.42) | 0.22 | (0.11) | 0.66 | |
| DIHRX | Intal High Relative | (5.94) | 7 per month | 0.57 | 0.02 | 1.07 | (1.26) | 3.04 | |
| BXHCX | Barings High Yield | 6.94 | 1 per month | 0.00 | (0.28) | 0.25 | (0.25) | 0.86 | |
| PARCX | T Rowe Price | 0.04 | 1 per month | 0.22 | 0.05 | 0.82 | (0.73) | 5.12 |
Biotechnology Fund Additional Predictive Modules
Most predictive techniques to examine Biotechnology price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Biotechnology using various technical indicators. When you analyze Biotechnology charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Biotechnology Fund Predictive Indicators
The successful prediction of Biotechnology Fund stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Biotechnology Fund Class, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Biotechnology Fund based on analysis of Biotechnology Fund hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Biotechnology Fund's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Biotechnology Fund's related companies.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Fund financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Fund security.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |